Age- and gender-related differences in teicoplanin levels in paediatric patients | Zendy

Volker Strenger | Zendy; Nora Hofer | Zendy; Siegfried Rödl | Zendy; M. Hönigl | Zendy; Reinhard B. Raggam | Zendy; Markus G. Seidel | Zendy; Hans Jürgen Dornbusch | Zendy; Daniela Sperl | Zendy; H. Lackner | Zendy; Wolfgang Schwinger | Zendy; Petra Sovinz | Zendy; Martin Benesch | Zendy; Berndt Urlesberger | Zendy; C. Urban | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Age- and gender-related differences in teicoplanin levels in paediatric patients

Author(s) -

Volker Strenger,

Nora Hofer,

Siegfried Rödl,

M. Hönigl,

Reinhard B. Raggam,

Markus G. Seidel,

Hans Jürgen Dornbusch,

Daniela Sperl,

H. Lackner,

Wolfgang Schwinger,

Petra Sovinz,

Martin Benesch,

Berndt Urlesberger,

C. Urban

Publication year - 2013

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkt176

Subject(s) - teicoplanin , medicine , dosing , gastroenterology , fluorescence polarization immunoassay , antibiotics , vancomycin , bacteria , microbiology and biotechnology , biology , staphylococcus aureus , genetics

Teicoplanin is a glycopeptide antibiotic active against Gram-positive bacteria, including methicillin-resistant staphylococci. While teicoplanin trough levels (TTLs) >10 mg/L are commonly considered appropriate, levels >20 mg/L are aimed for in the treatment of severe infections. Due to toxicity, it is recommended to avoid levels >60 mg/L.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research